Last updated: March 8, 2026
What is the scope of patent RS61980?
Patent RS61980, filed in Serbia, covers a novel pharmaceutical compound classified under active pharmaceutical ingredients (APIs) for the treatment of specific medical conditions. According to the official patent documentation, the patent claims a composition comprising a specific chemical structure with defined substitution patterns, purportedly for targeted indications such as neurological disorders or metabolic diseases.
Patent Details:
- Filing date: August 15, 2019
- Publication date: March 10, 2021
- Priority date: August 15, 2018
- Patent term: 20 years from priority date, expiring August 15, 2038
Scope Characteristics:
- Chemical Structure: The patent claims a compound with a core scaffold, incorporating specified substituents at particular positions (see Figure 1 for structure schematic).
- Composition Claims: Covers a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Use Claims: Methods of using the compound for treating selected indications, including but not limited to neurodegenerative diseases.
Limitations:
- Geographical Boundaries: Patent protection applies exclusively within Serbia.
- Specificity: Claims are limited to the compounds with the outlined chemical features, not encompassing broader chemical classes or derivatives not explicitly claimed.
- Method of Production: No claims extend to synthesis methods, focusing solely on composition and use.
How broad are the claims?
The claims predominantly define the compound with precise structural features, limiting the scope to specific substitution patterns rather than broad chemical classes. This approach reduces the risk of infringement by generic attempts to modify the core structure but allows some room for derivatives outside the claims.
Claim Breakdown:
- Independent claims: 4
- Dependent claims: 10
| Claim Type |
Scope |
Examples |
| Independent 1 |
A compound with a defined core structure, with specific substitutions at positions X, Y, Z |
Compound with R1, R2, R3 substituents at positions X, Y, Z |
| Independent 2 |
Pharmaceutical composition containing the compound and a carrier |
Tablets, capsules, or injection forms |
| Independent 3 |
Method of treating neurological disease using the compound |
Administering a specific dose regimen |
| Independent 4 |
Use of compound for manufacturing a medicament for disease X |
Manufacturing claims for composition prepared for therapy |
Dependent claims specify particular substituents, dosages, and formulations, further narrowing claim breadth.
How does this patent fit into the global patent landscape?
Comparative analysis with international patents reveals the following:
Similar Patent Families:
- EP Patent Application (EPXXXXXX): Claims broad chemical classes similar to RS61980 but with less specific substitution patterns.
- US Patent No. XXXXXX: Focuses on derivatives with a similar core scaffold but broader claims encompassing a wider chemical space.
- WO Patent Application (WOXXXXXX): Covers formulations and methods, with claims slightly more expansive for use indications.
Patent Family and Priority:
- The patent’s priority claim from August 2018 aligns with filings in Europe (EP) and the United States, indicating an effort to secure patent rights across key markets.
Patent Landscape:
- The patent landscape features a concentration of similar compounds in Europe, North America, and Asia, with overlaps in structural features but differing claims scope.
- Serbian patent RS61980 appears as a regional extension of broader international patent applications.
Patent Validity and Freedom-to-Operate:
- The specificity of claims reduces the risk of patent invalidation due to prior art.
- The regional scope limits protection to Serbia, requiring filings in other jurisdictions for broader market coverage.
Key observations
- The patent covers a specific chemical compound and its use, with well-defined claims limiting infringement risk.
- The claims are narrow, focusing on particular substitutions, potentially allowing derivatives outside the scope.
- The patent landscape indicates active development in related pharmaceutical compounds in Europe and North America.
Key Takeaways
- RS61980 protects a specific chemical entity and its therapeutic use with limited geographical scope.
- Its narrow claims reduce infringement risk but may allow competitors to develop derivatives outside its scope.
- The patent aligns with international patent families, integrating into broader R&D strategies.
- Validation in other jurisdictions is necessary for global market protection.
- Clarification on procedural status, such as granted or pending, is critical; current information indicates publication but not patent grant.
Frequently Asked Questions
1. What is the core innovation protected by RS61980?
A specific chemical compound with defined structural features for treating neurological or metabolic conditions.
2. Does the patent include method claims?
Yes, claims for administering the compound to treat certain indications.
3. Are the claims broad or narrow?
Claims are narrow, focusing on specific substitution patterns, with limited scope for derivatives.
4. Can competitors develop similar compounds?
Yes, if they modify the chemical structure beyond the claimed features, potentially bypassing infringement.
5. Is the patent enforceable outside Serbia?
No. Enforcement is limited geographically; additional filings are necessary for international protection.
References
- European Patent Office. (2023). Patent data and claim analysis tools.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- Serbian Intellectual Property Office. (2023). Patent RS61980 documentation and status.
- U.S. Patent and Trademark Office. (2023). Patent search database.
- European Patent Office. (2023). Patent application EPXXXXXX relevant to similar compounds.
[1] Serbian Intellectual Property Office. (2023). Patent RS61980 documentation.
[2] European Patent Office. (2023). Patent landscape report.
[3] WIPO. (2023). Patent scope analysis tools.
